| Dr Louis R Bouillon, MD | |
|
600 Mt. Pleasant Avenue, Suite A, Dover, NJ 07801 | |
| (973) 989-0888 | |
| (973) 989-0885 |
| Full Name | Dr Louis R Bouillon |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 45 Years |
| Location | 600 Mt. Pleasant Avenue, Dover, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730274473 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MA05058800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morristown Medical Center | Morristown, NJ | Hospital |
| Saint Clare's Hospital/ Denville Campus | Denville, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic Associates Of West Jersey, P.a. | 9436346590 | 3 |
News Archive
New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain. The data which were presented at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC) are from a multinational, crossover trial comparing Instanyl with oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in patients with cancer.
Homosexual, bisexual, and transgender youth tend to have a higher risk for suicide-related thoughts and behaviors, but research on interventions to prevent suicide among sexual and gender minority (SGM) youth has been limited.
Salmonella bacteria research from two recent NASA space missions discovered key elements of the bacteria's disease-causing potential that hold promise for improving ways to fight food-borne infections on Earth.
Researchers at the Translational Genomics Research Institute, the Van Andel Research Institute and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have discovered a biomarker that could help in the treatment of patients with an aggressive type of lung cancer.
ReSearch Pharmaceutical Services, Inc. (RPS) announced today it has entered into an agreement to sell the company to affiliates of Warburg Pincus, LLC, the global private equity firm, in an all cash transaction valued at $6.10 per share. The Board of Directors of RPS unanimously approved the acquisition agreement and recommended that RPS shareholders approve the transaction. It is presently anticipated that closing of the transaction will occur in February 2011.
› Verified 7 days ago
| Entity Name | Orthopedic Associates Of West Jersey, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639250756 PECOS PAC ID: 9436346590 Enrollment ID: O20101215000522 |
News Archive
New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain. The data which were presented at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC) are from a multinational, crossover trial comparing Instanyl with oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in patients with cancer.
Homosexual, bisexual, and transgender youth tend to have a higher risk for suicide-related thoughts and behaviors, but research on interventions to prevent suicide among sexual and gender minority (SGM) youth has been limited.
Salmonella bacteria research from two recent NASA space missions discovered key elements of the bacteria's disease-causing potential that hold promise for improving ways to fight food-borne infections on Earth.
Researchers at the Translational Genomics Research Institute, the Van Andel Research Institute and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have discovered a biomarker that could help in the treatment of patients with an aggressive type of lung cancer.
ReSearch Pharmaceutical Services, Inc. (RPS) announced today it has entered into an agreement to sell the company to affiliates of Warburg Pincus, LLC, the global private equity firm, in an all cash transaction valued at $6.10 per share. The Board of Directors of RPS unanimously approved the acquisition agreement and recommended that RPS shareholders approve the transaction. It is presently anticipated that closing of the transaction will occur in February 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Louis R Bouillon, MD 600 Mt. Pleasant Avenue, Suite A, Dover, NJ 07801 Ph: (973) 989-0888 | Dr Louis R Bouillon, MD 600 Mt. Pleasant Avenue, Suite A, Dover, NJ 07801 Ph: (973) 989-0888 |
News Archive
New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain. The data which were presented at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC) are from a multinational, crossover trial comparing Instanyl with oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in patients with cancer.
Homosexual, bisexual, and transgender youth tend to have a higher risk for suicide-related thoughts and behaviors, but research on interventions to prevent suicide among sexual and gender minority (SGM) youth has been limited.
Salmonella bacteria research from two recent NASA space missions discovered key elements of the bacteria's disease-causing potential that hold promise for improving ways to fight food-borne infections on Earth.
Researchers at the Translational Genomics Research Institute, the Van Andel Research Institute and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have discovered a biomarker that could help in the treatment of patients with an aggressive type of lung cancer.
ReSearch Pharmaceutical Services, Inc. (RPS) announced today it has entered into an agreement to sell the company to affiliates of Warburg Pincus, LLC, the global private equity firm, in an all cash transaction valued at $6.10 per share. The Board of Directors of RPS unanimously approved the acquisition agreement and recommended that RPS shareholders approve the transaction. It is presently anticipated that closing of the transaction will occur in February 2011.
› Verified 7 days ago
Mr. Arthur Harvey Tiger, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 Mt. Pleasant Ave., Suite E, Dover, NJ 07801 Phone: 973-989-8600 Fax: 973-989-1095 | |
Mrs. Kelly E Hoffman, PA-C Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 Mount Pleasant Ave, Dover, NJ 07801 Phone: 973-989-0888 | |
Dr. Steven Stecker, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 Mt Pleasant Avenue, Suite A, Dover, NJ 07801 Phone: 973-989-0888 Fax: 973-989-0885 | |
Dr. Joel H Spielman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 Mt. Pleasant Avenue, Suite A, Dover, NJ 07801 Phone: 973-989-0888 Fax: 973-989-0888 | |
Dr. Abraham H Rosenzweig, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 Mt. Pleasant Ave, Suite A, Dover, NJ 07801 Phone: 973-989-0888 Fax: 973-989-0885 |